Oruka Therapeutics, Inc. (ORKA) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 28 days, typically, give or take 7 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q2 FY2026Mon, Aug 10, 2026before open 41 8-K
Q1 FY2026Thu, Apr 30, 2026after close 30 8-K
Q2 FY2024Thu, Aug 1, 2024after close 32 8-K
Q1 FY2024Thu, Apr 25, 2024after close 25 8-K
Q4 FY2023Thu, Feb 1, 2024after close 32 8-K
Q3 FY2023Wed, Oct 18, 2023after close 18 8-K
Q2 FY2023Fri, Jul 21, 2023after close 21 8-K
Q1 FY2023Mon, Apr 24, 2023after close 24 8-K

What they guided beta

Q2 FY2026 "EVERLAST-A Week 28 data expected at the end of 3Q 2026; 52-week data for all participants expected in December 2026" exhibit
Q2 FY2026 "EVERLAST-B fully enrolled ahead of schedule, with Week 16 data now expected in 4Q 2026" exhibit
Q2 FY2026 "Phase 3 program for ORKA-001 expected to begin in 1H 2027" exhibit
Q2 FY2026 "ORCA-SURGE Week 16 data accelerated, now expected in 1Q 2027" exhibit
Q2 FY2026 "ORKA-004, a novel half-life extended monoclonal antibody targeting TL1A, to enter the clinic in 4Q 2026" exhibit
Q2 FY2024 "ARCA believes that its current cash and cash equivalents, consisting primarily of money market funds, will be sufficient to fund its operations through the end of 2025." exhibit
Q2 FY2024 "G&A expenses in 2024 are expected to be higher than those in 2023 as we incur professional fees related to the Merger Agreement discussed above and maintain administrative activities to support our ongoing operations." exhibit
Q2 FY2024 "R&D expense in 2024 is expected to be lower than 2023 while we explore strategic alternatives." exhibit
Q2 FY2024 "These statements include, but are not limited to, express or implied statements relating to ARCA’s or Oruka’s management team’s expectations, hopes, beliefs, intentions or strategies regarding the future including, without limitation, statements regarding: the Proposed Transactions and the expected effects, perceived benefits or opportunities, including investment amounts from investors and expected proceeds, and related timing with respect thereto, expectations regarding or plans for discovery, preclinical studies, clinical trials and research and development programs, in particular with resp" exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ORKA
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ORKA

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

ORKA earnings date badge

HTML

<a href="https://veritasdata.dev/company/ORKA/"><img src="https://veritasdata.dev/embed/ORKA.svg" alt="ORKA earnings date" width="240" height="56"></a>

Markdown

[![ORKA earnings date](https://veritasdata.dev/embed/ORKA.svg)](https://veritasdata.dev/company/ORKA/)

Script

<script async src="https://veritasdata.dev/embed/ORKA.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ORKA"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.